Search - tctmd.com

Displaying 381 - 400 of 951

Sort: Relevancy | Date

Presentation TCT 2019

Special Presentation: "Healthcare, Remixed" by Dr. Zubin Damania (ZDoggMD)

Presenter: Zubin Damania

September 26, 2019

PURE Sturdy: New insights into anthropometrics and cardiovascular outcomes in 142,000 adults from 21 countries followed for 9 years

Presentation ESC 2019

PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years

Presenter: Darryl P. Leong

September 02, 2019

Presentation ESC 2019

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Presenter: Deepak Bhatt

September 01, 2019

Presentation CHIP Seattle 2019

How to get help when all help looks lost

Presenter: Ravi S. Hira

August 02, 2019

Presentation

RAS Inhibition Following TAVR

July 29, 2019

Presentation SCCT 2019

Patients with high risk of CAD but no known CAD should go to CTA first vs. Functional first

Presenter: Marcelo F. Di Carli

July 11, 2019

Presentation TVT 2019

Reactions From the Cardiology Community

Presenter: Blase Carabello

June 13, 2019

Presentation ARCH 2019

Renal Denervation: Update of Trials

Presenter: Jason Fontana

April 12, 2019

Presentation ARCH 2019

Hypertension Treatment: Current Guidelines and New Treatment Modalities

Presenter: Marcos Rothstein

April 12, 2019

Presentation Fellows 2019

Welcome and Course Objectives

Presenter: Ajay J. Kirtane

April 12, 2019

Presentation ARCH 2019

Evaluation of Hypotension in or after the Cath Lab

Presenter: Adrian Messerli

April 11, 2019

Presentation SIF 2019

When Lightning Strikes Twice

Presenter: Nadia Sutton

March 29, 2019

Presentation CIT 2019

Renal Denervation and Therapies for Hypertension

Presenter: Murray Esler

March 28, 2019

Presentation CIT 2019

Where I See the Ideal Role for Renal Denervation Therapies

Presenter: Tony Walton

March 28, 2019

Presentation ECHO/IMAGING 2019

Echocardiographic Approach to the CHD: Evaluating the Unoperated Adult

Presenter: William R. Miranda

March 24, 2019

Presentation ECHO/IMAGING 2019

Approach to Congenital Heart Disease II: Evaluating the Postoperative Adult

Presenter: Heidi M. Connolly

March 24, 2019

Presentation ECHO/IMAGING 2019

Mechanical Complications of Acute Myocardial Infarction

Presenter: Brandon M. Wiley

March 23, 2019

Ticagrelor Monotherapy Beyond One Month Versus Conventional Therapy On Adjudicated Ischemic And Bleeding Endpoints Following Drug Eluting Sent Implantation. Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presentation ACC 2019

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presenter: Marco Valgimigli

March 18, 2019

Presentation ACC 2019

First Randomized Human Experience with a Ticagrelor Reversal Agent

Presenter: Deepak L. Bhatt

March 18, 2019

Presentation JIM 2019

Consider Low Dose RIVAROXABAN + SAPT

Presenter: Roxana Mehran

February 15, 2019

Advertisement

Special Presentation: "Healthcare, Remixed" by Dr. Zubin Damania (ZDoggMD)

PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

How to get help when all help looks lost

RAS Inhibition Following TAVR

Patients with high risk of CAD but no known CAD should go to CTA first vs. Functional first

Reactions From the Cardiology Community

Renal Denervation: Update of Trials

Hypertension Treatment: Current Guidelines and New Treatment Modalities

Welcome and Course Objectives

Evaluation of Hypotension in or after the Cath Lab

When Lightning Strikes Twice

Renal Denervation and Therapies for Hypertension

Where I See the Ideal Role for Renal Denervation Therapies

Echocardiographic Approach to the CHD: Evaluating the Unoperated Adult

Approach to Congenital Heart Disease II: Evaluating the Postoperative Adult

Mechanical Complications of Acute Myocardial Infarction

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

First Randomized Human Experience with a Ticagrelor Reversal Agent

Consider Low Dose RIVAROXABAN + SAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content